Unknown

Dataset Information

0

Tumour dormancy and clinical implications in breast cancer.

ABSTRACT: The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients develop metastases many years after apparently successful treatment of their primary cancer. Tumour dormancy may explain the long time between initial diagnosis and treatment of cancer, and occurrence of relapse. The regulation of the switch from clinical dormancy to cancer regrowth in locoregional and distant sites is poorly understood. In this review, we report some data supporting the existence of various factors that may explain cancer dormancy including genetic and epigenetic changes, angiogenic switch, microenvironment, and immunosurveillance. A better definition and understanding of these factors should allow the identification of patients at high risk of relapse and to develop new therapeutic strategies in order to improve prognosis.

SUBMITTER: Gelao L 

PROVIDER: S-EPMC3660156 | biostudies-other | 2013

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Tumour dormancy and clinical implications in breast cancer.

Gelao L L   Criscitiello C C   Fumagalli L L   Locatelli M M   Manunta S S   Esposito A A   Minchella I I   Goldhirsch A A   Curigliano G G  

Ecancermedicalscience 20130521

The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients develop metastases many years after apparently successful treatment of their primary cancer. Tumour dormancy may explain the long time between initial diagnosis and treatment of cancer, and occurrence of relapse. The regulation of the switch from clinical dormancy to cancer regrowth in locoregional and distant sites is poorly understood. In this review, we report some data supporting the existence of  ...[more]

Similar Datasets

Unknown The perivascular niche regulates breast tumour dormancy.
| S-EPMC3826912 | biostudies-literature
Transcriptomics Modeling androgen deprivation therapy-induced prostate cancer dormancy and its clinical implications
2022-01-11 | GSE193500 | GEO
Transcriptomics Breast Tumor Clinical Implications
2005-08-25 | GSE3193 | GEO
Transcriptomics Breast Tumor Clinical Implications
2005-08-25 | E-GEOD-3193 | biostudies-arrayexpress
Unknown Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.
| S-EPMC9234014 | biostudies-literature
Unknown Controversies in clinical cancer dormancy.
| S-EPMC3145712 | biostudies-other
Unknown When dormancy fuels tumour relapse.
| S-EPMC8209066 | biostudies-literature
Unknown Genomic instability in breast cancer: pathogenesis and clinical implications.
| S-EPMC2904860 | biostudies-other
Unknown A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy.
| S-EPMC6745044 | biostudies-other
Unknown In vitro Models of Breast Cancer Metastatic Dormancy.
| S-EPMC7062644 | biostudies-literature